← back to search

Lina Zhao

Jilin Normal University · CN
🔎 Find collaborators in Radiology, Nuclear Medicine and Imaging · Surgery →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Radiology, Nuclear Medicine and Imaging · Surgery
Research interest
Research interests include Radiomics and Machine Learning in Medical Imaging, Esophageal Cancer Research and Treatment, Advanced Radiotherapy Techniques, and Head and Neck Cancer Studies.
h-index
41
citations
7,066
works
372
NIH funding
primary concept
email

Recent publications

Performance of Machine Learning Models Based on Medical Imaging in Predicting the expression of PD-L1 and CD8+TILs in Thoracic cancer: A Systematic Review and Meta-Analysis
Academic Radiology 2026cited by 0position: contributordoi
3D tumor cultures for drug resistance and screening development in clinical applications.
2025cited by 25position: contributordoi
Multiple large language models versus experienced physicians in diagnosing challenging cases with gastrointestinal symptoms.
2025cited by 14position: contributordoi
Exploring the dosimetric advantages of a novel multi-modality radiotherapy platform in prostate cancer.
2025cited by 2position: contributordoi
Repeatability and prognostic value of radiomic features: a study in esophageal cancer and nasopharyngeal carcinoma.
2025cited by 1position: contributordoi
Validation and refinement of the 8th edition of the AJCC staging system for esophageal squamous cell carcinoma treated with definitive IMRT or chemo-IMRT: a Chinese multi-institutional retrospective study
Radiation Oncology 2025cited by 0position: middledoi
Primary Orbital Lymphoma Manifesting as Increased Intraocular Pressure: A Case Report
American Journal of Case Reports 2025cited by 0position: lastdoi
A novel multimodal adaptive delineation model for primary tumors and lymph node metastases in multi-center nasopharyngeal carcinoma radiotherapy
Computer Methods and Programs in Biomedicine 2025cited by 0position: contributordoi
Multi-omics approaches for biomarker discovery in predicting the response of esophageal cancer to neoadjuvant therapy: A multidimensional perspective.
2024cited by 31position: contributordoi
High-dose hyperfractionated simultaneous integrated boost radiotherapy versus standard-dose radiotherapy for limited-stage small-cell lung cancer in China: a multicentre, open-label, randomised, phase 3 trial.
2024cited by 26position: contributordoi
A CT-based subregional radiomics nomogram for predicting local recurrence-free survival in esophageal squamous cell cancer patients treated by definitive chemoradiotherapy: a multicenter study.
2024cited by 6position: contributordoi
RecurIndex-Guided postoperative radiotherapy with or without Avoidance of Irradiation of regional Nodes in 1–3 node-positive breast cancer (RIGAIN): a study protocol for a multicentre, open-label, randomised controlled prospective, phase III trial
BMJ Open 2024cited by 4position: middledoi
Using high-repeatable radiomic features improves the cross-institutional generalization of prognostic model in esophageal squamous cell cancer receiving definitive chemoradiotherapy.
2024cited by 3position: contributordoi
The gap before real clinical application of imaging-based machine-learning and radiomic models for chemoradiation outcome prediction in esophageal cancer: a systematic review and meta-analysis.
2023cited by 27position: contributordoi
Surgery versus radiotherapy for limited-stage small cell esophageal carcinoma: a multicenter, retrospective, cohort study in China (ChiSCEC)
International Journal of Surgery 2023cited by 15position: middledoi
Radiotherapy Improves Survival of Patients With Lymphovascular Invasion in pT1b Esophageal Squamous Cell Cancer After Endoscopic Submucosal Dissection
The American Journal of Gastroenterology 2023cited by 11position: middledoi
Development of Recombinase Aided Amplification (RAA)-Exo-Probe Assay for the Rapid Detection of Shiga Toxin-Producing <i>Escherichia coli</i>
Journal of AOAC International 2023cited by 9position: middledoi
Individualized intervention based on a preparation-related prediction model improves adequacy of bowel preparation: A prospective, multi-center, randomized, controlled study
Digestive and Liver Disease 2023cited by 2position: middledoi
Quality assurance in a phase III, multicenter, randomized trial of POstmastectomy radioThErapy in Node posiTive breast cancer with or without Internal mAmmary nodaL irradiation (POTENTIAL): a planning benchmark case
Radiation Oncology 2023cited by 1position: middledoi
Pattern of lymph node metastases and its implication in radiotherapeutic clinical target volume in patients with small cell carcinoma of the esophagus: A multicenter retrospective trial from China (CHiSCEC)
Research Square 2023cited by 0position: middledoi
CT-based radiomics nomogram may predict local recurrence-free survival in esophageal cancer patients receiving definitive chemoradiation or radiotherapy: A multicenter study.
2022cited by 43position: contributordoi
International consensus on radiotherapy in metastatic non-small cell lung cancer
Translational Lung Cancer Research 2022cited by 34position: middledoi
Prevalence, antibiotic resistance, and molecular epidemiology of Listeria monocytogenes isolated from imported foods in China during 2018 to 2020
International Journal of Food Microbiology 2022cited by 30position: middledoi
Insight of Silkworm Pupa Oil Regulating Oxidative Stress and Lipid Metabolism in Caenorhabditis elegans
Foods 2022cited by 15position: firstdoi
Variability of Target Volumes and Organs at Risk Delineation in Breast Cancer Radiation Therapy: Quality Assurance Results of the Pretrial Benchmark Case for the POTENTIAL Trial
Practical Radiation Oncology 2022cited by 11position: middledoi
Suppressor of cytokine signaling 6 in cancer development and therapy: Deciphering its emerging and suppressive roles.
2022cited by 8position: contributordoi
Long-Term Clinical Outcomes and Safety Analysis of Superficial Esophageal Cancer Patients Treated with Definitive or Adjuvant Radiotherapy.
2022cited by 8position: contributordoi
Canopy Fibroblast Growth Factor Signaling Regulator 2 (CNPY2) Inhibits Neuron Apoptosis in Parkinson’s Disease via the AKT/GSK3β Pathway
Current Neurovascular Research 2021cited by 6position: middledoi
Inhibition of SOCS6 confers radioresistance in esophageal squamous cell carcinoma.
2021cited by 5position: contributordoi
Inhibition of cell proliferation and radioresistance by miR-383-5p through targeting RNA binding protein motif (RBM3) in nasopharyngeal carcinoma.
2021cited by 5position: contributordoi

Grants

No grants ingested yet.

Frequent collaborators

· 6 papers (2024–2026)Xiaoyu Kang · Inner Mongolia Agricultural University4 papers (2016–2023)Hui Luo · Xiamen University4 papers (2016–2023)Hui Jia · Shandong University3 papers (2016–2018)Linhui Zhang · Tianjin University of Traditional Chinese Medicine3 papers (2016–2023)Felix W. Leung · University of California, Los Angeles3 papers (2016–2018) · 2 papers (2022–2023)Jing Jin · Soochow University2 papers (2022–2023)Xiaohong Wang · Chongqing University2 papers (2022–2023)Xiangping Wang · Huazhong University of Science and Technology2 papers (2016–2018) · 2 papers (2016–2018)Jian Tie · Ministry of Education2 papers (2022–2023) · 2 papers (2022–2023)Weifang Yang · Wenzhou Medical University2 papers (2022–2023) · 2 papers (2018–2023)Yuchun Song · East China University of Science and Technology2 papers (2022–2023)Jinling Shen · University of Maryland, College Park2 papers (2022–2023)Yufei Lu · Fudan University2 papers (2022–2023)Zhaohui Xiong · Hebei Medical University2 papers (2021–2025) · 2 papers (2023–2023)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Radiology, Nuclear Medicine and Imaging · Surgery →